Effectiveness And Safety of EGFR-TKIs as first line treatment in patients with NSCLC and harbouring EGFR mutation

Simple item page
dc.contributor.advisorTewodros, Eguale
dc.contributor.authorABDULLAH SALAH D ALANAZI
dc.date2019
dc.date.accessioned2022-06-02T03:52:25Z
dc.date.available2022-06-02T03:52:25Z
dc.degree.departmentPharmacoeconomics and policy
dc.identifier.other37740
dc.identifier.urihttps://drepo.sdl.edu.sa/handle/20.500.14154/61644
dc.publisherSaudi Digital Library
dc.titleEffectiveness And Safety of EGFR-TKIs as first line treatment in patients with NSCLC and harbouring EGFR mutation
dc.typeThesis
sdl.thesis.levelDoctoral
sdl.thesis.sourceSACM - United States of America

Files

Collections

SACM - United States of America

Copyright owned by the Saudi Digital Library (SDL) © 2025